Biotechnology Consulting and Investmentsp. z o.o.
Research and experimental development on biotechnology
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2013-10-17
Share capital
5,000.00 PLN
Registered address
32, 68-343 Brody, Poland
Electronic delivery address
AE:PL-74925-80302-UIECC-30
Financials
Revenue history
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 83 days late).
- 202506/07/2026
- 202403/07/2025
- 202327/06/2024
- 202205/07/2023
- 202106/10/2022
- 202014/10/2021
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 0.04MedianUSD 55.24kAverageUSD 2.70m
Net profit
This companyUSD -434.22MedianUSD -1.27kAverageUSD -92.18k
Operating costs
This companyUSD 434.25MedianUSD 65.85kAverageUSD 2.66m
Assets
This companyUSD 391.92kMedianUSD 133.19kAverageUSD 3.03m
Industry
Authorized Representatives
Andrzej Janusz Kryzar – President of the Management Board
Manner of representation
Each member of the management board is authorized to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 48 | $1,296.60 | 96% | |
Others | 2 | $54.02 | 4% |
Beneficial owners
| Person | Rights |
|---|---|
Subsidiaries
| Name | Share value | Stake | ||
|---|---|---|---|---|
Medcervinsp. z o.o. | 364,667.75 USD | 29.2081% |
Bank accounts
Registered as a VAT taxpayer on 2013-08-21.
20 1240 6768 1111 0010 5489 4324
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Greenetoxsp. z o.o. | $3,013.95 | greenetox.com | ||
| Passio Human Microbiomesp. z o.o. | $1,856.58 | passiohumanmicrobiome.com | ||
| Dairy Biotechnologiessp. z o.o. | $1,485.09 | milcu.eu | ||
| Medical Algorithmssp. z o.o. | $682.08 | medicalalgorithms.eu | ||
| Centrum Transferu Technologii Meditransfer Iitdsp. z o.o. | $228.56 | iitd.pan.wroc.pl | ||
| Fungotechsp. z o.o. | $187.68 | fungo.tech | ||
| Wavex Energysp. z o.o. | $142.33 | wavexenergy.com | ||
| Ncage TherapeuticsS.A. | $29.14 | ncage.org | ||
| Innervisionsp. z o.o. | $4.54 | innervision.pl | ||
| ImmunotronicsP.S.A. | $0.16 | immunotronics.net |
Change history
| Date | Event | |
|---|---|---|
| 2015-09-03 | PKD change (Removed: 15 codes) | |
| 2013-10-17 | Entered in the register |
FAQ
The main business activity of Biotechnology Consulting And Investment focuses on research and experimental development on biotechnology.
The company was registered in the Polish National Court Register (KRS) on October 17, 2013.
The headquarters is located at: 32, 68-343 Brody.
The management board consists of: Andrzej Janusz Kryzar (President of the Management Board).
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2024 to December 31, 2024.
The company reported a revenue of $33 in 2024, which is a decrease of 89.0% compared to 2023.
No, the company recorded a net loss of $1,111 in 2024. For comparison, in 2023 the loss was $746, meaning the company increased its loss by 41.3%.
The largest operating cost category falls under external services. This category amounted to $1,140 in 2024, representing 100% of all operating expenses.
Last updated: 2026-07-09